← Leaderboards
V Michael Holers
University Of Colorado Denver
$38,234,826
Attributed
$40,920,881
Total exposure
23
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,236,166 · 26
By mechanism
R01$15,358,716 · 6
UM2$10,766,323 · 5
U19$6,774,019 · 4
U01$6,156,893 · 1
UH2$5,485,653 · 1
P30$4,575,097 · 3
Top collaborators
- Paul Joseph Utz12 shared
- Joshua M Thurman6 shared
- Judith A James2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- George S Eisenbarth$13,354,570
- Taylor Triolo$571,189
- Todd M Bull$3,801,048
Others in their field
Top investigators on “Rheumatoid Arthritis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Lionel B Ivashkiv · Hospital For Special Surgery$38,096,851
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- Michael B Brenner · Brigham And Women'S Hospital$26,598,289
- Betty Diamond · Feinstein Institute For Medical Research$20,428,564
- Gary Steven Firestein · University Of California San Diego$19,402,936
Research focus
Rheumatoid ArthritisTissuesSystemic Lupus ErythematosusPathway InteractionsAutoimmune DiseasesBaseAutoantibodiesInflammationAutoantigensResearch PersonnelAntigensCellsSamplingCohortInflammatoryAutoimmunityFundingAffectCollaborationsProgramsSiteArthritisDesignExhibits
Grant awards (138)
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis$654,010
P30 · FY2025 · AR · contact PI
Role of the Factor H Related Proteins in Kidney Disease$481,125
R01 · FY2025 · DK
Complement in the Pathogenesis of Autoimmune Arthritis$307,890
R01 · FY2025 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis Administrative Core$218,004
P30 · FY2025 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis$738,482
P30 · FY2024 · AR · contact PI
Role of the Factor H Related Proteins in Kidney Disease$534,582
R01 · FY2024 · DK
Complement in the Pathogenesis of Autoimmune Arthritis$331,837
R01 · FY2024 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis Administrative Core$166,226
P30 · FY2024 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis$750,550
P30 · FY2023 · AR · contact PI
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2023 · DK
Complement in the Pathogenesis of Autoimmune Arthritis$342,100
R01 · FY2023 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis Administrative Core$167,503
P30 · FY2023 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis$762,580
P30 · FY2022 · AR · contact PI
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2022 · DK
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis Administrative Core$169,192
P30 · FY2022 · AR · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$95,012
R01 · FY2022 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis$777,500
P30 · FY2021 · AR · contact PI
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis$634,627
U01 · FY2021 · AI · contact PI
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2021 · DK
Complement in the Pathogenesis of Autoimmune Arthritis$342,100
R01 · FY2021 · AR · contact PI
Research Training in Rheumatology$295,977
T32 · FY2021 · AR · contact PI
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis Administrative Core$171,050
P30 · FY2021 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$706,719
UH2 · FY2020 · AR · contact PI
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis$627,429
U01 · FY2020 · AI · contact PI
AMP RA/SLE Leadership Center$530,673
UM2 · FY2020 · AR
Novel Therapeutic Approaches for Lupus Nephritis$440,908
R01 · FY2020 · DK
Research Training in Rheumatology$343,975
T32 · FY2020 · AR · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$342,100
R56 · FY2020 · AR · contact PI
Research Training in Rheumatology INCLUDE Down Syndrome Supplement$85,655
T32 · FY2020 · AR · contact PI
AMP RA/SLE Leadership Center$848,993
UM2 · FY2019 · AR
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis$635,263
U01 · FY2019 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$342,100
R01 · FY2019 · AR · contact PI
Research Training in Rheumatology$289,096
T32 · FY2019 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$238,824
UH2 · FY2019 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$86,151
UH2 · FY2019 · AR · contact PI
Research Training in Rheumatology - Down Syndrome Supplement$79,365
T32 · FY2019 · AR · contact PI
AMP RA/SLE Leadership Center$1,927,228
UM2 · FY2018 · AR
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis$642,873
U01 · FY2018 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$342,100
R01 · FY2018 · AR · contact PI
Research Training in Rheumatology$300,362
T32 · FY2018 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$300,001
UH2 · FY2018 · AR · contact PI
Colorado Autoimmunity Center of Excellence$77,750
UM1 · FY2018 · AI · contact PI
AMP RA/SLE Leadership Center$1,383,702
UM2 · FY2017 · AR
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$1,075,873
UH2 · FY2017 · AR · contact PI
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis$674,895
U01 · FY2017 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$342,100
R01 · FY2017 · AR · contact PI
Research Training in Rheumatology$305,858
T32 · FY2017 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$235,057
UH2 · FY2017 · AR · contact PI
Colorado Autoimmunity Center of Excellence$77,750
UM1 · FY2017 · AI · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$991,672
UH2 · FY2016 · AR · contact PI
AMP RA/SLE Leadership Center$890,185
UM2 · FY2016 · AR
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction for$458,970
U01 · FY2016 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$342,100
R01 · FY2016 · AR · contact PI
Research Training in Rheumatology$266,488
T32 · FY2016 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$155,500
UH2 · FY2016 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$103,854
UH2 · FY2016 · AR · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA through Established Disease$92,000
UH2 · FY2016 · AR · contact PI
Colorado Autoimmunity Center of Excellence$77,750
UM1 · FY2016 · AI · contact PI
AMP RA/SLE Leadership Center$952,770
UM2 · FY2015 · AR
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$750,001
UH2 · FY2015 · AR · contact PI
Leadership Center Research, Coordination, Managment and Statistics Program$654,935
UM2 · FY2015 · AR
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction for$464,562
U01 · FY2015 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$341,550
R01 · FY2015 · AR · contact PI
Research Training in Rheumatology$273,313
T32 · FY2015 · AR · contact PI
Systems Biology and Bioinformatics Group$217,519
UM2 · FY2015 · AR
Tissue Acquisition Research Group$80,316
UM2 · FY2015 · AR
Colorado Autoimmunity Center of Excellence$77,708
UM1 · FY2015 · AI · contact PI
AMP RA/SLE Leadership Center$1,640,001
UM2 · FY2014 · AR
Co-fund$1,128,000
UM2 · FY2014 · AR
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction for$1,072,868
U01 · FY2014 · AI · contact PI
Evolving Adaptive and Effector Mechanisms from Pre-RA Through Established Disease$750,001
UH2 · FY2014 · AR · contact PI
Systems Biology and Bioinformatics Group$236,365
UM2 · FY2014 · AR
Colorado Autoimmunity Center of Excellence$232,375
UM1 · FY2014 · AI · contact PI
Research Training in Rheumatology$219,292
T32 · FY2014 · AR · contact PI
Disconnecting CR2/CD21 from Its C3d Ligand to Ameliorate Lupus$193,489
R21 · FY2014 · AI · contact PI
Tissue Acquisition Research Group$170,666
UM2 · FY2014 · AR
Leadership Center Research, Coordination, Managment and Statistics Program$104,970
UM2 · FY2014 · AR
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction for$442,666
U01 · FY2013 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$340,566
R01 · FY2013 · AR · contact PI
Research Training in Rheumatology$259,063
T32 · FY2013 · AR · contact PI
Disconnecting CR2/CD21 from Its C3d Ligand to Ameliorate Lupus$231,438
R21 · FY2013 · AI · contact PI
Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction for$502,740
U01 · FY2012 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$358,491
R01 · FY2012 · AR · contact PI
Research Training in Rheumatology$233,542
T32 · FY2012 · AR · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$358,491
R01 · FY2011 · AR · contact PI
Rheumatoid Arthritis: Biomarkers of Progression from Autoimmunity to Disease$332,675
U19 · FY2011 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$373,428
R01 · FY2010 · AR · contact PI
Rheumatoid Arthritis: Biomarkers of Progression from Autoimmunity to Disease$368,924
U19 · FY2010 · AI · contact PI
Research Training in Rheumatology$148,476
T32 · FY2010 · AR · contact PI
Rheumatoid Arthritis: Biomarkers of Progression from Autoimmunity to Disease$380,357
U19 · FY2009 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$378,192
R01 · FY2009 · AR · contact PI
Research Training in Rheumatology$180,044
T32 · FY2009 · AR · contact PI
Rheumatoid Arthritis: Biomarkers of Progression from Autoimmunity to Disease$581,817
U19 · FY2008 · AI · contact PI
RA-Related Autoantibodies in Healthy FDR of RA Patients$496,573
R01 · FY2008 · AR · contact PI
Mouse Membrane RCA Proteins in the Immune Response$333,030
R01 · FY2008 · AI · contact PI
Research Training in Rheumatology$176,480
T32 · FY2008 · AR · contact PI
Rheumatoid Arthritis: Biomarkers of Progession from autoimmunity to disease$1,154,610
U19 · FY2007 · AI · contact PI
Denver Autoimmunity Center of Excellence$816,365
U19 · FY2007 · AI · contact PI
RA-Related Autoantibodies in Healthy FDR of RA Patients$506,707
R01 · FY2007 · AR · contact PI
Mouse Membrane RCA Proteins in the Immune Response$339,480
R01 · FY2007 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$285,951
R01 · FY2007 · AR · contact PI
Research Training in Rheumatology$163,498
T32 · FY2007 · AR · contact PI
Rheumatoid Arthritis: Progession /autoimmunity to diseas$1,246,620
U19 · FY2006 · AI · contact PI
Denver Autoimmunity Center of Excellence$821,029
U19 · FY2006 · AI · contact PI
RA-Related Autoantibodies in Healthy FDR of RA Patients$521,841
R01 · FY2006 · AR · contact PI
Mouse Membrane RCA Proteins in the Immune Response$349,619
R01 · FY2006 · AI · contact PI
Complement in the Pathogenesis of Autoimmune Arthritis$294,491
R01 · FY2006 · AR · contact PI
C3d/EBV Receptor Ligand Binding Sites$246,120
R01 · FY2006 · CA · contact PI
Research Training in Rheumatology$170,623
T32 · FY2006 · AR · contact PI
Denver Autoimmunity Center of Excellence$821,216
U19 · FY2005 · AI
RA-Related Autoantibodies in Healthy FDR of RA Patients$588,400
R01 · FY2005 · AR
Mouse Membrane RCA Proteins in the Immune Response$358,032
R01 · FY2005 · AI
Complement in the Pathogenesis of Autoimmune Arthritis$301,578
R01 · FY2005 · AR
C3d/EBV Receptor Ligand Binding Sites$252,042
R01 · FY2005 · CA
Evolution of Autoimmunity in Rheumatoid Arthritis$192,500
R21 · FY2005 · AI
RESEARCH TRAINING IN RHEUMATOLOGY$127,866
T32 · FY2005 · AR
Mouse Membrane RCA Proteins in the Immune Response$371,157
R01 · FY2004 · AI
Complement in the Pathogenesis of Autoimmune Arthritis$315,078
R01 · FY2004 · AR
C3d/EBV Receptor Ligand Binding Sites$252,042
R01 · FY2004 · CA
Evolution of Autoimmunity in Rheumatoid Arthritis$192,500
R21 · FY2004 · AI
RESEARCH TRAINING IN RHEUMATOLOGY$186,929
T32 · FY2004 · AR
Denver Autoimmunity Center of Excellence$1
U19 · FY2004 · AI
C3d/EBV Receptor Ligand Binding Sites$255,915
R01 · FY2003 · CA
RESEARCH TRAINING IN RHEUMATOLOGY$188,041
T32 · FY2003 · AR
MOUSE MEMBRANE RCA PROTEINS IN THE IMMUNE RESPONSE$295,123
R01 · FY2002 · AI
C3d/EBV Receptor Ligand Binding Sites$255,412
R01 · FY2002 · CA
RESEARCH TRAINING IN RHEUMATOLOGY$46,194
T32 · FY2002 · AR
Cartilage/Bone Biology: Pathogenesis-Joint Destruction$27,954
R13 · FY2002 · AR
RA Associated Autoimmunity in high risk populations$0
U19 · FY2002 · AI
AntiC5 therapy of lupus nephritis$0
U19 · FY2002 · AI
MOUSE MEMBRANE RCA PROTEINS IN THE IMMUNE RESPONSE$288,465
R01 · FY2001 · AI
C3D/EBV RECEPTOR LIGAND BINDING SITES$211,081
R01 · FY2001 · CA
RESEARCH TRAINING IN RHEUMATOLOGY$56,014
T32 · FY2001 · AR
RA Associated Autoimmunity in high risk populations$0
U19 · FY2001 · AI
AntiC5 therapy of lupus nephritis$0
U19 · FY2001 · AI
MOUSE MEMBRANE RCA PROTEINS IN THE IMMUNE RESPONSE$281,727
R01 · FY2000 · AI
AntiC5 therapy of lupus nephritis$250,405
U19 · FY2000 · AI
C3D/EBV RECEPTOR LIGAND BINDING SITES$241,456
R01 · FY2000 · CA